Category Regional Policy

US Supreme Court Rules On Pharma Payments To Delay Generic Drugs On Market

The United States Supreme Court in a five to three decision today found that settlement agreements by branded pharmaceutical companies involving payments to generic companies to delay their cheaper drugs' entry into the market may not be immune from antitrust scrutiny but are not "presumptively" unlawful. The case was sent back to lower court.

US Supreme Court Restricts Gene Patents … A Little

Last Thursday, the United States Supreme Court overturned more than 30 years of precedents and ruled that isolated genes cannot be patented. They are products of nature and thus not patent-eligible subject matter, the court unanimously held in Assoc. for Molecular Pathology v. Myriad Genetics, Inc. This ruling puts the US at odds with most other nations, which allow genes to be patented. But because other major nations grant narrower gene patents, the net effect of Myriad will be to shift the US position on gene patents closer to that of other nations.

EU Commissioner: PRISM Will Hurt US Businesses, Create EU Opportunities

European Commission Vice-President responsible for the Digital Agenda, Neelie Kroes, today told a US business group that revelations about the United States government's mass surveillance programmes would hurt US businesses, but create opportunities for European business. She also said the US should have been more transparent with the European Union and allow US companies to be more transparent, and risks undermining trust in digital services.